|
⚲
|
| Keyboard |
| Mark Boulding | |
|---|---|
| Firm | |
| Address | c/o Ptc Therapeutics, Inc 100 Corporate Court South Plainfield, NJ 07080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| PTC Therapeutics Inc | 021-481052 | Executive Officer | 35.9 M of 35.9 M |
||
| PTC Therapeutics Inc | 021-368872 | Executive Officer | 41.9 M of 41.9 M |
||
| PTC Therapeutics Inc | 021-366976 | Executive Officer | 140.9 M of 140.9 M |
||
| PTC Therapeutics Inc | 021-320688 | Executive Officer | 150.0 M of 150.0 M |
||
| PTC Therapeutics Inc | 021-196557 | Executive Officer | 4.5 M of 4.5 M |
||
| PTC Therapeutics Inc | 021-193682 | Executive Officer | 60.0 M of 60.0 M |
||
| PTC Therapeutics Inc | 021-191684 | Executive Officer | 2.0 M of 16.1 M |
||
| PTC Therapeutics Inc | 021-179680 | Executive Officer | 23.0 M of 40.0 M |
||
| PTC Therapeutics Inc | 021-61608 | Executive Officer | 25.2 M of 50.3 M |
||
| Related People Network |
|---|
| Network #239 at PTC Therapeutics Inc — files alongside 35 co-filers |